H O Hallander
Overview
Explore the profile of H O Hallander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlsson R, Gustafsson L, Hallander H, Ljungman M, Olin P, Gothefors L, et al.
Vaccine
. 2015 Jun;
33(31):3717-25.
PMID: 26057135
Prior study children from a DTaP efficacy trial were recruited at ages 5 and 15 years to randomized booster trials addressing immunogenicity and reactogenicity; 475 preschool children received mixed or...
2.
van Gent M, Heuvelman C, van der Heide H, Hallander H, Advani A, Guiso N, et al.
Eur J Clin Microbiol Infect Dis
. 2014 Dec;
34(4):821-30.
PMID: 25527446
Despite more than 50 years of vaccination, pertussis is still an endemic disease, with regular epidemic outbreaks. With the exception of Poland, European countries have replaced whole-cell vaccines (WCVs) by...
3.
Zeddeman A, van Gent M, Heuvelman C, van der Heide H, Bart M, Advani A, et al.
Euro Surveill
. 2014 Aug;
19(33).
PMID: 25166348
Pathogen adaptation has been proposed to contribute to the resurgence of pertussis. A striking recent example is the emergence of isolates deficient in the vaccine component pertactin (Prn). This study...
4.
Adamsson L, Dornbusch K, Hallander H
J Antimicrob Chemother
. 2009 Oct;
8 Suppl B:153-62.
PMID: 19802979
Of 39 cephalothin-resistant (MIC > or =16 mg/l) strains of Enterobacteriaceae, 50% were inhibited by cefamandole 4 mg/l, cefoperazone 1 mg/l, cefuroxime 16 mg/l, cefoxitin 8 mg/l, ceftazidime 0.5 mg/l...
5.
Advani A, Van der Heide H, Hallander H, Mooi F
J Microbiol Methods
. 2009 Jul;
78(3):297-301.
PMID: 19577594
Three Bordetella pertussis typing methods, pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and multi-locus variable number tandem repeat analysis (MLVA) were compared using a collection of Swedish strains. Of...
6.
van Amersfoorth S, Schouls L, Van der Heide H, Advani A, Hallander H, Bondeson K, et al.
J Clin Microbiol
. 2005 Jun;
43(6):2837-43.
PMID: 15956406
Despite the widespread use of pertussis vaccines during the last decades, pertussis has remained an endemic disease with frequent epidemic outbreaks. Currently two types of vaccines are used: whole-cell vaccines...
7.
Olin P, Hallander H
Euro Surveill
. 2003 Mar;
4(12):128-129.
PMID: 12631878
Immunisation against pertussis with an acellular pertussis vaccine for children at 3, 5, and 12 months was included in the Swedish vaccination programme in January 1996, 17 years after the...
8.
Hallander H, Paniagua M, Espinoza F, Askelof P, Corrales E, Ringman M, et al.
Vaccine
. 2002 Nov;
21(1-2):138-45.
PMID: 12443672
Serum responses to oral cholera vaccines were assessed in three paediatric vaccine trials, two in León, Nicaragua and one in Stockholm, Sweden. A calibrated anti-cholera toxin B subunit (CTB) IgA...
9.
Olin P, Hallander H, Gustafsson L, Reizenstein E, Storsaeter J
Clin Infect Dis
. 2001 Dec;
33 Suppl 4:S288-91.
PMID: 11709761
Studies on serologic correlates to protection in pertussis were reviewed. Trials in the 1950s showed that agglutinogen titers correlated to protection of whole-cell vaccines, but postvaccination antibodies against pertussis toxin...
10.
Edmunds W, Pebody R, Aggerback H, Baron S, Berbers G, Conyn-Van Spaendonck M, et al.
Epidemiol Infect
. 2000 Nov;
125(1):113-25.
PMID: 11057967
Seven countries in Western Europe collected large, representative serum banks across the entire age range and tested them for diphtheria anti-toxin (sample size ranged from 2991 to 7715). Although a...